Cite
HARVARD Citation
Lee, J. et al. (2018). Histone deacetylase inhibitor (HDACi) upregulates activin A and activates the Smad signaling pathway in melanomas. Journal of dermatological science. 90 (1), pp. 13-20. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, J. et al. (2018). Histone deacetylase inhibitor (HDACi) upregulates activin A and activates the Smad signaling pathway in melanomas. Journal of dermatological science. 90 (1), pp. 13-20. [Online].